That, in turn, can lead to serious or even fatal heart issues like arrhythmias or valvular heart disease.
So far, there’s been little research on the link between repeated psychedelics use and heart health, but this week, researchers at the University of Fribourg Center for Psychiatric Research in Switzerland published a paper in the Journal of Psychopharmacology reviewing the existing evidence.
“It is possible that chronic microdosing may carry a risk of fibrosis and valvular heart disease, which should be assessed in future studies,” the authors write.
“Any future work considering longer microdosing regimens should incorporate breaks and regular screening for vascular abnormalities.”